Concepedia

Ari G. Olroyd

AG

Statistics

Publications

3

Citations

305

H-Index

3

Active since

2023

Affiliations

Sana Biotechnology (United States)(Current)

University of California, San Francisco

Ari G. Olroyd is an author at Sana Biotechnology (United States) specializing in cell therapy, pancreatic islet cells, and pancreatic islet engraftment.

ORCID

Publications per year

2023–2024

3

Publications

3

Hypoimmune induced pluripotent stem cells survive long term in fully immunocompetent, allogeneic rhesus macaques

Xiaomeng Hu, Kathy White, Ari G. Olroyd et al. · Nature Biotechnology · 2023 · 148 citations · Full text

, , +17

Human hypoimmune primary pancreatic islets avoid rejection and autoimmunity and alleviate diabetes in allogeneic humanized mice

Xiaomeng Hu, Corie Gattis, Ari G. Olroyd et al. · Science Translational Medicine · 2023 · 97 citations

, , +16

Hypoimmune islets achieve insulin independence after allogeneic transplantation in a fully immunocompetent non-human primate

Xiaomeng Hu, Kathy White, Chi Young et al. · Cell stem cell · 2024 · 60 citations · Full text

, , +16

1–3 of 3